- Jeremy F L Cobbold, clinical lecturer,
- Quentin M Anstee, clinical lecturer ,
- Howard C Thomas, professor of medicine
- 1Hepatology and Gastroenterology Section, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London W2 1NY
- Correspondence to: Q M Anstee q.anstee{at}imperial.ac.uk
A 43 year old man of South Asian origin, working as a software engineer, was found to have a serum alanine aminotransferase value of 64 (normal range 0-40) U/l at a routine health check arranged by his company. He had an unremarkable medical history and took no regular medications. Of note, his father had died of ischaemic heart disease at the age of 67 years. Clinical examination was unremarkable. His height was 1.7 m and weight 79 kg (body mass index 27). The results of the remaining basic liver blood tests were normal (bilirubin 12 (0-20) μmol/l; alkaline phosphatase 105 (30-150) U/l; albumin 38 (35-50) g/l). Full blood count and serum urea, creatinine, and electrolytes were also within normal limits.
What is the next investigation?
An initial history and clinical examination are necessary for determining the likely aetiology of the raised alanine aminotransferase value, the presence of any comorbidity that may accelerate disease progression, and the presence of stigmata of chronic liver disease. History should include details of alcohol intake, risk factors for chronic viral hepatitis, use of prescription medication, and over the counter or herbal remedies.
Liver biochemistry
The general practitioner requested a repeat serum alanine aminotransferase value (which was 58 U/l) and serum aspartate aminotransferase and γ glutamyltransferase values (52 (0-40) U/l and 55 (11-51) U/l respectively).
Raised serum alanine aminotransferase values usually indicate hepatocellular damage. Aminotransferase values of less than five times the upper limit of normal are often considered mild, while those more than five times the upper limit of normal are severe, representing more extensive hepatocellular injury. Mildly raised values do not exclude severe chronic liver disease; indeed evidence exists that substantial liver damage may be present …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10
Published 16 May 2012
Re: Outcomes of elective induction of labour compared with expectant management: population based study
Published 16 May 2012
Re: Outcomes of elective induction of labour compared with expectant management: population based study
Published 16 May 2012
Re: Why the US healthcare system is failing, and what might rescue it
Published 16 May 2012
Re: Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
Published 16 May 2012
Most responses
Is spending on proton beam therapy for cancer going too far, too fast? (11 responses)
Published 17 Apr 2012 - 23:32
What are the benefits of an early diagnosis? (8 responses)
Published 18 Apr 2012
The psychiatric oligarchs who medicalise normality (8 responses)
Published 2 May 2012
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21